General
Preferred name
ELLAGIC ACID
Synonyms
ML062 ()
ICX5609072 ()
Gallogen ()
Lagistase ()
Elagostasine ()
Elagostasine, Gallogen ()
Ellagic Acid hydrate ()
Ellagic acid dihydrate ()
NSC-656272 ()
NSC-407286 ()
Acido elagico ()
Acide ellagique ()
P&D ID
PD001339
CAS
476-66-4
122328-15-8
133039-73-3
314041-08-2
Tags
available
nuisance
drug candidate
obsolete probe
probe
natural product
Drug indication
Discovery agent
Follicular lymphoma
Drug Status
investigational
Max Phase
2.0
Probe info
Probe type
experimental probe
Probe sources
MLP Probes
Probe targets
[[ compound.targets[t].gene_name ]]
Probe control
Probe control not defined
Orthogonal probes
7
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ellagic acid is a plant-derived phenolic compound, that is found in cranberries, strawberries, raspberries, pomegranates, and in some vegetables and nuts. Its biological effects have been proposed for therapeutic potential, however there is no scientific evidence that supports clinical efficacy in serious medical conditions (cancer, heart disease). The pharmacological properties of urolithin ellagic acid metabolites have also been reported .
(GtoPdb)
PRICE
29
PRICE
58
DESCRIPTION
1. Transfer and run the HTS assay for the DNA polymerase III Holoenzyme (Pol III HE) from the representative Gram (-) model organism E. coli. 2. Prioritize compounds identified via HTS of the MLSCN library for further chemical optimization and development.
(MLP Probes)
DESCRIPTION
Ellagic acid (Gallogen), a thickened tetracyclic natural product, is a potent CK2 inhibitor (IC50=40 nM; Ki=20 nM) with ATP-competitive properties. Ellagic acid is an antioxidant and also possesses antiproliferative activity.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Ellagic acid is a natural antioxidant, and acts as a potent and ATP-competitive CK2 inhibitor. Ellagic acid is being investigated for use in follicular lymphoma, brain injury in intrauterine growth restricted babies, obese adolescents, and solar lentigines.
(Enamine Bioactive Compounds)
DESCRIPTION
Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
3
Organisms
4
Compound Sets
22
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
LINCS compound set
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
MLP Probes
Novartis Chemogenetic Library (NIBR MoA Box)
Nuisance compounds in cellular assays
Obsolete Compounds
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
49
Molecular Weight
302.01
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
4
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
4
cLogP
1.31
TPSA
141.34
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.22
Structural alerts
2
historic compounds (Chemical Probes.org)
Obsolete
Nonspecific/NOS
Nuisance compounds
Related compounds
Custom attributes
(extracted from source data)
Pathway
NF-¦ÊB
Angiogenesis
Chromatin/Epigenetic
Cytoskeletal Signaling
DNA Damage/DNA Repair
GPCR/G protein
Immunology/Inflammation
Metabolism
NF-κB
Stem Cells
Tyrosine Kinase/Adaptors
Cell Cycle/DNA Damage
Metabolic Enzyme/Protease
Protein Tyrosine Kinase/RTK
Stem Cell/Wnt
Target
Carbonic Anhydrase
Casein kinase
CK2
Endogenous Metabolite
PKA
PKC
Reactive Oxygen Species
Smoothened
SYK
Topo I
CYP1A1
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK
Reactive Oxygen Species (ROS)
SHP2
Topoisomerase
MOA
Hedgehog/Smoothened antagonist
Syk antagonist
cAMP-Dependent Protein Kinase (PKA) Inhibitors
Inhibitors of Signal Transduction Pathways
PKB alpha/Akt1 Inhibitors
LOXL2-dependent prodrug inhibitor of TGFBR
glutathione transferase inhibitor, non-nucleoside reverse transcriptase inhibitor
Member status
virtual
Source data
